Clinical efficacy of istradefylline on lower urinary tract symptoms in Parkinson’s disease: A prospective study
Objective: The aim of the present study was to determine the effects of istradefylline, adenosine A2A receptor antagonist on lower urinary tract symptoms (LUTS) in…Prodromal Parkinson’s disease in Argentinean patients with Gaucher disease type 1: Preliminary report
Objective: To describe prodromal symptoms or signs of Parkinson's disease (PD) in a type 1 Gaucher Disease cohort (GD). Background: Mutations in the acid b-glucocerebrosidase…Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s disease
Objective: Our aim was to compare hypothalamic volumes in PD patients with matched controls, and determine whether volume loss correlated with reduced melatonin output in…Pain correlates with sleep disturbances in Parkinson’s disease
Objective: This study aimed to 1) examine the clinical characteristics of pain in patients with Parkinson's disease(PD) and 2) explore the correlation between pain and…Depression, anxiety, and apathy in Parkinson’s disease: Insights from neuroimaging studies
Objective: (1) To evaluate the existing neuroimaging studies of depression, anxiety and apathy in Parkinson's disease (PD) and (2) to determine the key neural pathway…The non-motors symptoms in Parkinson’s disease patients with freezing of gait
Objective: To reveal the prevalence of the non-motors symptoms and clinical features differences between Parkinson's disease (PD) patients with and without freezing of gait (FOG).…Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases
Objective: To address the co-occurrence of the burden of non-motor symptoms staging (NMSB) and motor severity of Parkinson's disease (PD) using the Hoehn and Yahr…Allele specificity in neurodegenerative olfactory dysfunction
Objective: Assess olfactory dysfunction in carriers of the p.N279K and p.P301L MAPT mutations, which cause FTDP-17, to understand how genotypic differences contribute to the severity…Parkinson’s disease is characterised by differences in lower limb joint kinetics during stair ascent and descent
Objective: To investigate the contribution of the hip, knee and ankle joint moments to support moments during stair ascent and descent in people with Parkinson's…Disease progression and clinical characteristics of Parkinson’s disease patients with type 1 diabetes – An analysis on 18,162 patients from the DPV registry
Objective: To determine if type 1 diabetes (T1DM) mellitus patients with Parkinson's disease (PD) exhibit similar characteristics of disease progression as T1DM patients without PD.…
- « Previous Page
- 1
- …
- 62
- 63
- 64
- 65
- 66
- …
- 207
- Next Page »